Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tazi, A.
Right arrow Articles by Hance, A. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tazi, A.
Right arrow Articles by Hance, A. J
Thorax 2000;55:405-416 ( May )

Review series

Rare diseases bullet  9

Adult pulmonary Langerhans' cell histiocytosis

Abdellatif Tazi, Paul Soler, Allan J Hance

Correspondence to: Dr A J Hance

The first 150 words of the full text of this article appear below.

    Introduction

In the early 1950s Lichtenstein introduced the term histiocytosis X to describe a group of syndromes with seemingly unrelated clinical features, but whose pathological findings were characterised by the infiltration of involved tissues with large numbers of unusual histiocytes, often organised as granulomas.1 Subsequently it was shown that these histiocytes were similar to Langerhans' cells normally present in the skin and other epithelia, a finding that led to the current designation of Langerhans' cell histiocytosis (LCH) for this group of disorders.2 3

Although the different forms of LCH are united by a common histopathological finding---the Langerhans' cell granuloma---the clinical spectrum of these disorders is extremely large, extending from an acute disseminated form which usually occurs in infants and carries a poor prognosis, to the presence of lesions localised to a single tissue which follows a more benign clinical course (table 1).4-8 Pulmonary involvement is not unusual in systemic . . . [Full text of this article]




This article has been cited by other articles:


Home page
J HeredHome page
J. T. Soller, H. M. Escobar, S. Willenbrock, M. Janssen, N. Eberle, J. Bullerdiek, and I. Nolte
Comparison of the Human and Canine Cytokines IL-1({alpha}/{beta}) and TNF-{alpha} to Orthologous Other Mammalians
J. Hered., August 3, 2007; (2007) esm025v3.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J.-F. Cordier
Challenges in pulmonary fibrosis {middle dot} 2 : Bronchiolocentric fibrosis
Thorax, July 1, 2007; 62(7): 638 - 649.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Tazi
Adult pulmonary Langerhans' cell histiocytosis.
Eur. Respir. J., June 1, 2006; 27(6): 1272 - 1285.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Caminati and S. Harari
Smoking-related Interstitial Pneumonias and Pulmonary Langerhans Cell Histiocytosis.
Proceedings of the ATS, January 1, 2006; 3(4): 299 - 306.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
U. B.S. Prakash
Uncommon Causes of Cough: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 206S - 219S.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
G. F. Abbott, M. L. Rosado-de-Christenson, T. J. Franks, A. A. Frazier, and J. R. Galvin
From the Archives of the AFIP: Pulmonary Langerhans Cell Histiocytosis
RadioGraphics, May 1, 2004; 24(3): 821 - 841.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. L. Mendez, H. F. Nadrous, R. Vassallo, P. A. Decker, and J. H. Ryu
Pneumothorax in Pulmonary Langerhans Cell Histiocytosis
Chest, March 1, 2004; 125(3): 1028 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J., October 1, 2003; 22(4): 672 - 688.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. M. Fleming, J.-A. O. Shepard, and E. J. Mark
Case 15-2003 - A 47-Year-Old Man with Waxing and Waning Pulmonary Nodules Five Years after Treatment for Testicular Seminoma
N. Engl. J. Med., May 15, 2003; 348(20): 2019 - 2027.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J.H. Ryu, T.V. Colby, T.E. Hartman, and R. Vassallo
Smoking-related interstitial lung diseases: a concise review
Eur. Respir. J., January 1, 2001; 17(1): 122 - 132.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & British Thoracic Society